NY S07499 | 2021-2022 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Engrossed on May 24 2022 - 50% progression, died in committee
Action: 2022-05-24 - referred to health
Pending: Assembly Health Committee
Text: Latest bill text (Amended) [HTML]

Summary

Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs.

Sponsors


Roll Calls

2022-05-24 - Senate - Senate Floor Vote - Final Passage (Y: 48 N: 13 NV: 0 Abs: 2) [PASS]
2022-05-09 - Senate - Senate Health Committee Vote (Y: 9 N: 5 NV: 0 Abs: 1) [PASS]

History

DateChamberAction
2022-05-24Assemblyreferred to health
2022-05-24SenateDELIVERED TO ASSEMBLY
2022-05-24SenatePASSED SENATE
2022-05-17SenateADVANCED TO THIRD READING
2022-05-17SenateAMENDED 7499B
2022-05-16Senate2ND REPORT CAL.
2022-05-11Senate1ST REPORT CAL.1338
2022-05-05SenatePRINT NUMBER 7499A
2022-05-05SenateAMEND (T) AND RECOMMIT TO HEALTH
2022-01-05SenateREFERRED TO HEALTH
2021-11-03SenateREFERRED TO RULES

Same As/Similar To

A00663 (Same As) 2022-05-19 - print number 663b

New York State Sources


Bill Comments

feedback